DDR1 and prostate carcinoma: At the same time, a report of the International Stand Up to Cancer/American Association for Cancer Research Prostate Cancer/Prostate Cancer Foundation Team (SU2C-PCF) identified genomic alterations affecting DDR genes in 23% of the 150 metastatic biopsy samples analysed.